NCT02725268 2021-11-24A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial CancerTakedaPhase 2 Completed241 enrolled 22 charts